In early May, CURE has been highlighted in an article presenting the project and its first results. The article can be found here.
Furthermore, EFA did an interview with Prof. Dr. Johan Garssen, Member of the CURE Scientific Advisory Board, who is a “strong believer in the potential of phage therapies”. Click here to read the full interview.